Pison Attracts Equity Investment From Samsung Ventures

Samsung Venture Investment Corporation (Samsung Ventures) has made an equity investment in Pison, a developer of artificial intelligence (AI)-powered neural sensors for cognitive health, wellness, and gesture control. Neither company provided specifics about the investment.

The investment highlights Samsung Ventures’ dedication to advancing future healthcare technology and acknowledges Pison’s potential in neurocognitive assessment and tracking capabilities, according to both companies.

Pison was founded in 2016 with funding from the Massachusetts Institute of Technology, National Science Foundation, and the ALS Association. The company has also received funding from several Small Business Innovation Research (SBIR) awards from the U.S. Department of Defense, and various research institutions. In addition, the FY2025 National Defense Authorization Act (NDAA) highlights the value of neural biosensors for advancing warfighter health and readiness, namely detecting traumatic brain injuries and tracking chronic fatigue.

Pison’s sensor technology detects brain activity from three nerve bundles in the wrist. Using both active and passive AI algorithms, it extracts neurocognitive data, providing insights into mental acuity and impairment from poor sleep, chronic fatigue, anxiety, neurodegenerative conditions, drugs, alcohol, and subconcussive brain injuries.

“We’re honored to have Samsung Venture Investment Corporation involved in this funding journey for Pison, as their support offers vital resources to bring forward transformative solutions with meaningful societal impact,” Pison CEO John Croteau said. “Our mobile apps and subscription services aim to redefine cognitive performance and productivity—whether at home, on the athletic field, in the workplace, or within mission-critical job functions.”

Founded in 1999, Samsung Venture Investment is the corporate venture capital arm of Samsung Electronics based in Seoul, South Korea. The firm prefers to invest in companies operating in semiconductors, telecommunication, software, internet, bioengineering, and medical sectors across Europe, Asia, and North America.

Pison is advancing the frontier of human potential with (reportedly) the world’s first AI-powered, neural sensing platform. Patented, non-invasive electroneurography (ENG) algorithms and the introduction of a new sensor array create life-changing applications in cognitive performance, disease diagnostics and management, and quality of life. Pison aims to help patients with neurodegenerative disorders better navigate a world made smaller by their diseases. By harnessing the power of the mind in real-time, users gain access to better health and higher achievement in every domain while reaching peak mental and physical performance on the playing field, at work, and in everyday life.